Ronnett B M, Carmichael M J, Carter H B, Epstein J I
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
J Urol. 1993 Aug;150(2 Pt 1):386-9. doi: 10.1016/s0022-5347(17)35488-5.
Prior studies have evaluated high grade prostatic intraepithelial neoplasia on biopsy material when undiagnosed carcinoma or benign prostatic hyperplasia (BPH) may have been associated with elevated serum prostate specific antigen (PSA) levels. We studied 65 totally embedded radical prostatectomy specimens with minimal carcinoma (tumor volume 0.5 cc or less) and relatively minimal BPH (gland weight less than 65 gm.). Even for these relatively small glands, PSA showed a significant correlation with gland volume (r = 0.64). To account for BPH, PSA density (PSA divided by gland volume) was also calculated. In these specimens with trivial tumor the tumor volume did not correlate with PSA (r = 0.12) or PSA density (r = 0.23). The volume of high grade prostatic intraepithelial neoplasia also showed no correlation with PSA (r = 0.16) or PSA density (r = 0.14). The 11 cases with extensive high grade prostatic intraepithelial neoplasia (0.50 cc or more) had PSA density values of 0.03 to 0.14, with 10 less than 0.1. Of the 6 cases with PSA density values of 0.1 or more only 1 had a high grade prostatic intraepithelial neoplasia volume of 0.5 cc or more. These results indicate that high grade prostatic intraepithelial neoplasia in and of itself does not account for elevated serum PSA levels. In a patient with high grade prostatic intraepithelial neoplasia on biopsy material and elevated serum PSA values, BPH may account for the elevated serum PSA levels. More likely, because of the association between high grade prostatic intraepithelial neoplasia and carcinoma these patients have undiagnosed carcinoma as the source of the elevated serum PSA values.
既往研究在活检材料中评估高级别前列腺上皮内瘤变时,未诊断出的癌或良性前列腺增生(BPH)可能与血清前列腺特异性抗原(PSA)水平升高有关。我们研究了65例完全包埋的根治性前列腺切除术标本,这些标本癌灶极小(肿瘤体积0.5立方厘米或更小)且BPH相对较少(腺体重量小于65克)。即使对于这些相对较小的腺体,PSA与腺体体积也显示出显著相关性(r = 0.64)。为了考虑BPH的影响,还计算了PSA密度(PSA除以腺体体积)。在这些肿瘤微小的标本中,肿瘤体积与PSA(r = 0.12)或PSA密度(r = 0.23)均无相关性。高级别前列腺上皮内瘤变的体积与PSA(r = 0.16)或PSA密度(r = 0.14)也无相关性。11例高级别前列腺上皮内瘤变广泛(0.50立方厘米或更大)的病例,其PSA密度值为0.03至0.14,其中10例小于0.1。在6例PSA密度值为0.1或更高的病例中,只有1例高级别前列腺上皮内瘤变体积为0.5立方厘米或更大。这些结果表明,高级别前列腺上皮内瘤变本身并不能解释血清PSA水平升高。对于活检材料中有高级别前列腺上皮内瘤变且血清PSA值升高的患者,BPH可能是血清PSA水平升高的原因。更有可能的是,由于高级别前列腺上皮内瘤变与癌之间的关联,这些患者存在未诊断出的癌,这才是血清PSA值升高的根源。